Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Specific Membrane Antigen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05581979
What this trial is testing

PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers

Who this might be right for
Salivary Gland TumorRare Malignant Neoplasm
National Cancer Centre, Singapore 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT06964958
What this trial is testing

177LuPSMA in Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaAdvanced Clear Cell Renal Cell CarcinomaKidney Cancer
Dana-Farber Cancer Institute 24
Early research (Phase 1)Looking for participantsNCT07621692
What this trial is testing

Exploring Auger-Enhanced PSMA-Targeted Radioligand Therapy: A First-in-Taiwan Clinical Study of 161Tb-PSMA-I&T

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
National Taiwan University Hospital 12
Testing effectiveness (Phase 2)Study completedNCT03606837
What this trial is testing

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging

Who this might be right for
Prostate Cancer
University Hospital, Bordeaux 14
Not applicableLooking for participantsNCT07266129
What this trial is testing

Virtual Biopsy of Prostate Cancer Using PSMA PET and AI

Who this might be right for
Prostate Cancer (Diagnosis)
University Hospital of North Norway 220
Early research (Phase 1)Study completedNCT06641219
What this trial is testing

Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen

Who this might be right for
Prostate Cancers
Tomsk National Research Medical Center of the Russian Academy of Sciences 7
Testing effectiveness (Phase 2)WithdrawnNCT06199453
What this trial is testing

The Evaluation of the Effectiveness, Safety and Tolerability of Treatment, Using a PSMA-Lu177, in Patients with ACC- an Open, Non-commercial Clinical Trial

Who this might be right for
Adenoid Cystic Carcinoma
Maria Sklodowska-Curie National Research Institute of Oncology
Not applicableStudy completedNCT03453528
What this trial is testing

Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors

Who this might be right for
Prostate-specific Membrane AntigenmCRPC or Advanced/Metastatic Solid Tumors
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 1,225
Testing effectiveness (Phase 2)Study completedNCT03604757
What this trial is testing

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks

Who this might be right for
Prostate Cancer
University Hospital, Bordeaux 22
Testing effectiveness (Phase 2)Study completedNCT05670106
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 62
Not applicableEnded earlyNCT05995236
What this trial is testing

Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

Who this might be right for
Prostate Cancer
Methodist Health System 35
Not applicableLooking for participantsNCT06982469
What this trial is testing

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

Who this might be right for
Prostate CancerProstatectomyLocal Recurrence of Malignant Tumor of Prostate+2 more
Clinica Universidad de Navarra, Universidad de Navarra 20
Not applicableStudy completedNCT05534594
What this trial is testing

Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid CancerMedullary Thyroid CarcinomaThyroid Carcinoma, Medullary+1 more
University Medical Center Groningen 8
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05570994
What this trial is testing

177Lu-HTK03170 in mCRPC With PSMA Positive Disease

Who this might be right for
Metastatic Castration-resistant Prostate CancerProstate Cancer MetastaticCastrate Resistant Prostate Cancer
British Columbia Cancer Agency 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05896371
What this trial is testing

Personalized PSMA Radiopharmaceutical Therapy

Who this might be right for
CancerProstate CancerMetastatic Cancer+1 more
CHU de Quebec-Universite Laval 500
Post-approval studies (Phase 4)Looking for participantsNCT07569926
What this trial is testing

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 142
Not applicableStudy completedNCT05958004
What this trial is testing

The Application Value of Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA Grey Area Prostate Cancer

Who this might be right for
Prostatic Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 92
Not applicableStudy completedNCT03537391
What this trial is testing

Novel Imaging in Staging of Primary Prostate Cancer

Who this might be right for
High Risk Prostate Cancer
Turku University Hospital 80
Not applicableStudy completedNCT05522257
What this trial is testing

PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas

Who this might be right for
Sarcoma,Soft TissueUrothelial Carcinoma
Leiden University Medical Center 25
Large-scale testing (Phase 3)Study completedNCT04186819
What this trial is testing

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 356
Next Page